Asthma is a chronic, lifelong condition without a cure that can cause life-threatening symptoms and affects 3.8 million Canadians. 1–3 Although inhaled medication is the cornerstone of therapy, ...
AirDuo RespiClick and ArmonAir RespiClick are expected to be available later this year. Teva announced that the Food and Drug Administration (FDA) has approved two new breath-activated, multi-dose dry ...
Credit: Teva. The products contain a built-in electronic module that detects, records and stores data on inhaler events. Teva announced the launch of AirDuo® Digihaler® (fluticasone propionate and ...
Teva Respiratory is unveiling AirDuo Digihaler (fluticasone propionate and salmeterol) inhalation powder and ArmonAir Digihaler (fluticasone propionate) inhalation powder, two digital maintenance ...
The US Food and Drug Administration (FDA) has approved fluticasone furoate inhalation powder (Arnuity Ellipta, GlaxoSmithKline) as maintenance treatment for asthma in patients aged 12 years and older, ...
The researchers evaluated budesonide-glycopyrrolate-formoterol and fluticasone-umeclidinium-vilanterol in preventing COPD exacerbations and pneumonia hospitalizations in real-world settings. They ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback